Effectiveness of Dry Needling Adjuvant to Selective Serotonin Reuptake Inhibitors Versus Trigger Point Injection for Pain Management in Fibromyalgia Dry Needling Versus Trigger Point Injection in Fibromyalgia
Article Sidebar
Main Article Content
Abstract
Background: Fibromyalgia (FM) is a chronic condition characterized by widespread pain, fatigue, and mood disturbances. Management often involves pharmacological and non-pharmacological interventions, but optimal treatment strategies remain unclear.
Objective: To compare the effectiveness of dry needling combined with selective serotonin reuptake inhibitors (SSRIs) versus trigger point injections for pain management in fibromyalgia patients.
Methods: A randomized controlled trial was conducted with 42 fibromyalgia patients. Participants were randomly assigned to Group A (dry needling with SSRIs) or Group B (trigger point injections). Pain, depression, and fibromyalgia impact were assessed using the Visual Analog Scale (VAS), Beck Depression Inventory (BDI), and Fibromyalgia Impact Questionnaire (FIQ). Data were collected at baseline and after 8 weeks, and analyzed using SPSS 25. Statistical significance was set at p < 0.05.
Results: Group A showed greater reductions in pain (VAS: 5.3 ± 0.4 vs. 6.2 ± 0.2, p = 0.045), depression (BDI: 18.5 ± 2.1 vs. 20.5 ± 1.0, p = 0.001), and fibromyalgia impact (FIQ: 38.5 ± 3.2 vs. 44.0 ± 2.5, p = 0.003) compared to Group B.
Conclusion: Dry needling combined with SSRIs is more effective than trigger point injections in managing pain, depression, and overall symptoms in fibromyalgia patients.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Wolfe F, Rasker JJ. The evolution of fibromyalgia, its concepts, and criteria. Cureus. 2021;13(11).
Galvez-Sánchez CM, Reyes del Paso GA. Diagnostic criteria for fibromyalgia: Critical review and future perspectives. J Clin Med. 2020;9(4):1219.
Alciati A, Cirillo M, Masala IF, Sarzi‐Puttini P, Atzeni F. Differences in depression, anxiety, and stress disorders between fibromyalgia associated with rheumatoid arthritis and primary fibromyalgia. Stress Health. 2021;37(2):255-62.
Baloh RW. Fibromyalgia and chronic fatigue syndrome. In: Baloh RW, editor. Medically unexplained symptoms: A brain-centered approach. Springer; 2021. p. 141-57.
Barker S. Why has the 'Pain Revolution' not occurred? An analysis of the competition between material semiotic translations of pain in a neoliberal age. 2023.
Hackshaw K. Assessing our approach to diagnosing fibromyalgia. Expert Rev Mol Diagn. 2020;20(12):1171-81.
Creed F. A review of the incidence and risk factors for fibromyalgia and chronic widespread pain in population-based studies. Pain. 2020;161(6):1169-76.
Jones L. The experience of emotion in people with fibromyalgia: A thematic analysis [thesis]. University of the West of England; 2021.
Baitha U, Deb KS, Ranjan P, Mukherjee A, Bauddh NK, Kaloiya GS, et al. The estimated prevalence of medically unexplained physical symptoms in the medicine outpatient department of a tertiary care hospital in India. Gen Hosp Psychiatry. 2019;61:47-52.
Arif MA, Syed F, Niazi R, Arif SA, Hashmi UEL, Shah Z. The oracle study: Fibromyalgia, prevalence and severity in the hospital setting in the Pakistani population. J Pak Med Assoc. 2021;71(5):1357-68.
Bhargava J, Hurley JA. Fibromyalgia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019.
Gautschi RU. Trigger points as a fascia-related disorder. In: Findley TW, Schleip R, editors. Fascia: The tensional network of the human body. 2nd ed. Churchill Livingstone; 2021. p. 329-40.
Mazza DF, Boutin RD, Chaudhari AJ. Assessment of myofascial trigger points via imaging: A systematic review. Am J Phys Med Rehabil. 2021;100(10):1003-14.
Urits I, Charipova K, Gress K, Schaaf AL, Gupta S, Kiernan HC, et al. Treatment and management of myofascial pain syndrome. Best Pract Res Clin Anaesthesiol. 2020;34(3):427-48.
Evcik D, Ketenci A, Sindel D. The Turkish Society of Physical Medicine and Rehabilitation (TSPMR) guideline recommendations for the management of fibromyalgia syndrome. Turk J Phys Med Rehabil. 2019;65(2):111-26.
Yepez D, Grandes XA, Manjunatha RT, Habib S, Sangaraju SL. Fibromyalgia and depression: A literature review of their shared aspects. Cureus. 2022;14(5).
Appasamy M, Lam C, Alm J, Chadwick AL. Trigger point injections. Phys Med Rehabil Clin N Am. 2022;33(2):307-19.
Castro-Sánchez AM, Garcia-López H, Fernández-Sánchez M, Perez-Marmol JM, Leonard G, Gaudreault N, et al. Benefits of dry needling of myofascial trigger points on autonomic function and photoelectric plethysmography in patients with fibromyalgia syndrome. Acupunct Med. 2020;38(3):140-9.
Navarro-Santana MJ, Sanchez-Infante J, Fernández-de-Las-Peñas C, Cleland JA, Martín-Casas P, Plaza-Manzano G. Effectiveness of dry needling for myofascial trigger points associated with neck pain symptoms: An updated systematic review and meta-analysis. J Clin Med. 2020;9(10):3300.
Ackerman RS, Ahern PB, Patel BT, Noe CE. Soft tissue pain. In: Noe CE, editor. Multidisciplinary spine care. Springer; 2022. p. 121-36.
Fernández-de-Las-Peñas C, Nijs J. Trigger point dry needling for the treatment of myofascial pain syndrome: Current perspectives within a pain neuroscience paradigm. J Pain Res. 2019;12:1899-911.
Schulze NB, de Melo Salemi M, de Alencar GG, Moreira MC, de Siqueira GR. Efficacy of manual therapy on pain, impact of disease, and quality of life in the treatment of fibromyalgia: A systematic review. Pain Physician. 2020;23(5):461-70.
Nowak Z, Chęciński M, Nitecka-Buchta A, Bulanda S, Ilczuk-Rypuła D, Postek-Stefańska L, et al. Intramuscular injections and dry needling within masticatory muscles in management of myofascial pain: Systematic review of clinical trials. Int J Environ Res Public Health. 2021;18(18):9552.
Ananthan S, Kanti V, Zagury JG, Quek SY, Benoliel R. The effect of the twin block compared with trigger point injections in patients with masticatory myofascial pain: A pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129(3):222-8.